Inuti 100 Tablet SR contains Nitrofurantoin 100 mg, a broad-spectrum antibacterial agent primarily used in the treatment and prevention of urinary tract infections (UTIs) caused by susceptible strains of bacteria. Nitrofurantoin acts by inhibiting bacterial enzymes involved in carbohydrate metabolism and cell wall synthesis, leading to bacterial cell death. The sustained-release formulation ensures a gradual release of the active ingredient, maintaining effective plasma concentrations over an extended period, thereby enhancing therapeutic efficacy and improving patient compliance through reduced dosing frequency. Inuti 100 Tablet SR is indicated for acute and chronic infections of the lower urinary tract, including cystitis and urethritis, particularly when caused by Escherichia coli, Staphylococcus saprophyticus, and other susceptible organisms. It is contraindicated in patients with significant renal impairment, as reduced renal function may lead to inadequate urinary concentrations and increased risk of toxicity. Common adverse effects include gastrointestinal disturbances such as nausea, vomiting, and diarrhea, as well as hypersensitivity reactions. Caution is advised in patients with glucose-6-phosphate dehydrogenase deficiency due to risk of hemolytic anemia. Inuti 100 Tablet SR should be used under medical supervision, with dosage adjustments based on renal function and clinical response to ensure optimal safety and effectiveness.